Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H18ClNO2.ClH |
Molecular Weight | 292.201 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C[C@@H]1NC(C)(C)CO[C@@]1(O)C2=CC=CC(Cl)=C2
InChI
InChIKey=ORXTVTDGPVINDN-BTJVGWIPSA-N
InChI=1S/C13H18ClNO2.ClH/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10;/h4-7,9,15-16H,8H2,1-3H3;1H/t9-,13+;/m0./s1
Radafaxine (GW353162, ( )-(2S,3S)-2-(3-chlorophenyl-3,5,5-trimethyl-2-morphinol) or S,S-hydroxybupropion) is an active metabolite of bupropion. It acts as an inhibitor of the dopamine transporter. Radafaxine was investigated for the treatment of depression however, development was discontinued.
Originator
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
60 mg 1 times / day multiple, oral (unknown) Highest studied dose Dose: 60 mg, 1 times / day Route: oral Route: multiple Dose: 60 mg, 1 times / day Sources: |
unhealthy, ADULT n = 365 Health Status: unhealthy Condition: major depressive disorder Age Group: ADULT Sex: unknown Food Status: UNKNOWN Population Size: 365 Sources: |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00057213
Once-daily oral radafaxine (GW353162) (20-40-60mg) was investigated over an eight-week treatment period in phase 2 study in subjects with major depressive disorder
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB29224
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
PP-54
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
SYD411HZ3S
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL1172928
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
C78023
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
DBSALT002075
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
DTXSID90909896
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
106083-71-0
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
100000092737
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
9838996
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD